Home » Tenders » Europe » Luxembourg » Contract notice: Various medicinal products Tender, Luxembourg - 26865444

Contract notice: Various medicinal products Tender, Luxembourg - 26865444

FÉDÉRATION DES HÔPITAUX LUXEMBOURGEOIS (FHL), ASSOCIATION SANS BUT LUCRATIF has floated a tender for Contract notice: Various medicinal products. The project location is Luxembourg and the tender is closing on 16 Oct 2018. The tender notice number is 405030-2018, while the TOT Ref Number is 26865444. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Luxembourg

Summary : Contract notice: Various medicinal products

Deadline : 16 Oct 2018

Other Information

Notice Type : Tender

TOT Ref.No.: 26865444

Document Ref. No. : 405030-2018

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : FÉDÉRATION DES HÔPITAUX LUXEMBOURGEOIS (FHL), ASSOCIATION SANS BUT LUCRATIF
Office Name: Fédération des hôpitaux luxembourgeois (FHL), association sans but lucratif
Address: 5 rue des Mérovingiens
Town: Bertrange
Postal Code: 8070
Contact Point: Cellule marchés, à l'attention de Madame Carla Moreira et Monsieur Luc Waisse

Phone: +352 42414211
Fax: +352 42414281
Luxembourg
Email :carla.moreira@fhlux.lu
URL :http://www.fhlux.lu

Tender Details

Object of the contract
Various medicinal products

Description: Contract notice: Various medicinal products

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Competitive procedure with negotiation
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: The most economic tender
CPV code: 33690000, 33690000, 33690000
CPV Description: Various medicinal products.

Supply of infliximab to 4 institutions of the Federation of Luxembourg Hospitals.

Reference Number: Internal reference of the FHL: INFLIX18. PMP reference: 1801401

The object of the market is the supply of infliximab, divided into 2 lots, with associated services. The specifications of the lots are described in the description of the procedurehard selection. The establishments that will be parties to the contracts are the Emile Mayrisch Hospital Center (CHEM), the Luxembourg Hospital Center (CHL), the North Hospital Center (CHN) and the Robert Schuman Hospitals (HRS).

Infliximab of non-biosimilar status, injectable form, 100 mg.

See Article 4 of the description of the selection procedure.

Description of the salt procedureection can be downloaded from the website of the public markets portal: https://pmp.b2g.etat.lu. In case of difficulties to download the description of the selection procedure or to open it, please contact the Federation of Luxembourg Hospitals using the messaging service of the public markets portal. In the event of a malfunction, the e-mail addresses ofact are: carla.moreira@fhlux.lu; luc.waisse@fhlux.lu

Internet address (URL): http://www.fhlux.lu